期刊文献+

二甲双胍对多囊卵巢综合征患者内分泌功能的影响 被引量:7

Effect of metformin on endocrine function in patents with polycystic ovary syndrome
下载PDF
导出
摘要 目的探讨二甲双胍对多囊卵巢综合征(PCOS)合并胰岛素抵抗(IR)患者内分泌的影响。方法 P-COS合并IR患者50例于自然月经或撤退性出血第2天开始服用二甲双胍12周,观察治疗前后血清促卵泡生成素(FSH)、黄体生成素(LH)、睾酮、雌二醇、雄烯二酮、性激素结合蛋白(SHBG)浓度、胰岛素(INS)水平以及血糖的变化。结果治疗后患者各时相INS水平显著下降,差异有统计学意义(P<0.01);患者血清LH、LH/FSH比值、睾酮和雄烯二酮水平均显著下降,差异有统计学意义(P<0.01);SHBG水平显著升高,差异也有统计学意义(P<0.01)。结论二甲双胍通过改善IR降低INS水平,改善患者临床症状和内分泌指标,使PCOS患者异常的血激素相得到明显改善。 Objective To evaluate the effect of metformin on the endocrine function on the patients with polycystic ovary syndrome(PCOS) complicating with insulin resistance.Methods 50 patients with polycystic ovary syndrome complicating with insulin resistance began to taking metformin on 2 d of the natural menstruation or withdrawal bleeding for 12 weeks.Before and after treatment,serum luteinizing hormone(LH),follicle-stimulating hormone(FSH),estradiol(E2),testosterone(T),androstenedione(A),sex hormone binding globulin(SHBG),insulin and glucose concentrations were determined.Results After treatment,serum insulin levels were decreased significantly with statistical difference(P0.01).The serum LH,T,A concentrations and the ratio LH/FSH were decreased,showing statistical difference(P0.01).The SHBG levels were increased significantly with statistical difference(P0.01).Conclusion Metformin could improve abnormal insulinemia obviously by improving insulin resistance,reducing insulin level,improving clinical symptoms and endocrine indexes in the patients with PCOS.
作者 花冠杰
出处 《检验医学与临床》 CAS 2011年第2期135-136,139,共3页 Laboratory Medicine and Clinic
关键词 二甲双胍 多囊卵巢综合征 内分泌 胰岛素抗药性 metformin polycystic ovary syndrome endocrine insulin resistance
  • 相关文献

参考文献11

  • 1Franks S. Polycystic ovary syndrome[J]. N Engl J Med, 1995,333(5) :853-861.
  • 2Meirow D, Yossepowitch O, Rosier A, et al. Insulin resistant and non-resistant polycystie ovary syndrome represent two clinical and endocrinological subgroups[J]. Hum Reprod, 1995,10(11): 1951-1956.
  • 3Poretsky I,Piper B. Insulin resistance. Hypersecretion of LH and a dual-detect hypothesis for the pathogenesis of polycystic ovary syndrome [J]. Obstet Gynecol, 1994,84 (5) ..613-621.
  • 4The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Work Shop Group. Revised 2003 consensus on diagnostic criteria and tong term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004,19(1) :41-47.
  • 5张翠莲,高航云,赵志刚,贾萍.罗格列酮和二甲双胍治疗胰岛素抵抗多囊卵巢综合征的临床研究[J].中国实用妇科与产科杂志,2004,20(8):477-479. 被引量:26
  • 6Dunaif A. Insulin resistance and the Polycystic ovary syndrome:mechanism and implications for pathogenesia[J]. Endoer Rev, 1997,18(10) : 774-781.
  • 7吴效科,张祖暄,苏延华.多囊卵巢综合征患者脂代谢的研究[J].中华妇产科杂志,1998,33(1):25-27. 被引量:10
  • 8Bailyey CJ, Turner RC. Metformin drug therapy[J]. N Engl J Med,1996,334(8) :574-579.
  • 9Bergh C, Carlsson B, Olsson JH, et al. Regulation of androgen production in cultured human the cal cells by insulin-like growth factor I and insulin [J]. Fertil Steril, 1993,59 (4): 323-340.
  • 10Nestler JE,Powers LP, Matt AW. A direct effect of hyperinsulinemia on serum sex hormone biding globulin levels in obese women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 1991,72 ( 1 ) : 83-89.

二级参考文献15

  • 1吴效科,Acta Obstet Gynecol Scand,1996年,75卷,166页
  • 2林蓓,中华妇产科杂志,1995年,30卷,417页
  • 3汪俊军,中华医学检验杂志,1991年,14卷,198页
  • 4Haffner SM,Kennedy E,Gonzalez C,et al.A prospective analysis of the Homa model.The Mexico city diabetes study.Diabetes Care,1996,19:1138-1341
  • 5Moran C,Huerta R,Conway-Myers BA,et al.Altered autophosphorylation of the in sulin receptor in the ovary of a women with polycystic ovary syndrome.Fertil Steril,2001,75:625-628
  • 6Murakawa H,Hasegawa I,Kurabayashi T,et al.Polycystic ovary syndrome insulin resistance and ovulatory responses to clomiphene citrate.J Reprod Med,1999,44: 23-27
  • 7Mitwally MF,Kuscu NK,Yalcinkaya TM.High ovulatory rates with use of troglitaz one in clomiphene-resistant women with polycysticovary syndrome.Hum Reprod,199 9,14:2700-2703
  • 8Elazquez EM,Mendoza S,Hamer T,et al.Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia,insulin resistance,hyperandrogenemia,and systolic blood pressure,while facilitating normal menses and pregnancy.Metabolism,1994,4 3:647-654
  • 9Moghetti P,Castello R,Negri C,et al.Metformin effects on clinical fea tures,e ndocrine and metabolic profiles and insulin sensitivity in polycystic ovary synd rome:a randomized double-blind,placebo-controlled 6-month trial,followed by open long-term clini
  • 10Ng EH,Wat NM,Ho PC.Effects of metformin on ovulation rate,hormonal and meta bolic profiles in women with clomiphene-resistant polycystic ovaries:a randomized,double-blind placebo-controlled trial.Hum Reprod,2001,16:1625-1631

共引文献34

同被引文献56

引证文献7

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部